333-B1070, Nordic Biosite, Tby, Sweden) and the dipeptidyl peptidase (DPP)-4 inhibitor, sitagliptin (10 mg/kg, 5 uL/g, Xelevia
The result can be low potassium, or hypokalaemia, in the first days of treatment
Patients with diabetic retinopathy should be aware that rapid improvement in blood glucose with semaglutide may temporarily worsen retinopathy
A., De La Sacristana, A
Human clinical data specifically examining tirzepatide direct immune effects in autoimmune disease patients remains limited
Emerging Benefits of Microdosing Ozempic Ozempic and Alzheimers Disease Several clinical trials are investigating semaglutide, the active ingredient in Ozempic, as a potential treatment for Alzheimer's disease, with results expected in 2026